2001
DOI: 10.1053/joca.2000.0389
|View full text |Cite
|
Sign up to set email alerts
|

Tissue inhibitor of metalloprotease-1 (TIMP-1) serum level may predict progression of hip osteoarthritis

Abstract: TIMP-1 serum level may serve to predict the evolution of patients with hip OA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
23
0

Year Published

2002
2002
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(27 citation statements)
references
References 32 publications
4
23
0
Order By: Relevance
“…The strong induction of both MMPs and TIMP-1 suggests a role in tissue remodeling. Increased expression of both MMPs and TIMP-1 have been observed in human OA (40,41).…”
Section: Discussionmentioning
confidence: 98%
“…The strong induction of both MMPs and TIMP-1 suggests a role in tissue remodeling. Increased expression of both MMPs and TIMP-1 have been observed in human OA (40,41).…”
Section: Discussionmentioning
confidence: 98%
“…Eleven ''progression'' studies [7-9, 15, 17, 24, 29, 30, 35, 37, 39] investigated the association of 13 different biomarker levels with the progression of hip OA. Of the 11 studies, four looked at progression of known hip OA [9,15,37,39]; three studies investigated the progression to incident hip OA from unspecified prearthritic hip disease [8,17,29]; and four studies investigated both OA progression and incidence [7,24,30,35]. Duration of followup to evaluate OA progression ranged from 1 year to 15 years.…”
Section: Literature Searchmentioning
confidence: 99%
“…Despite numerous attempts to elucidate pathogenetic factors, the origin and the complex nature of rapidly destructive hip OA still remain unclear [3,7]. Radiographic findings in this disease can mimic those of other disorders, such as septic arthritis, rheumatoid and seronegative arthritis and primary osteonecrosis with secondary OA [21].…”
Section: Discussionmentioning
confidence: 99%
“…Accordingly, urinary levels of type II collagen C-telopeptide (CTX-II) have been reported to be significantly higher in patients with rapidly destructive hip OA than in patients with slowly progressive hip OA [8]. Increased levels of matrix metalloproteinases (MMP-3 and -9) and decreased levels of tissue inhibitor of matrix metalloproteinases (TIMP) in serum and joint fluid have pointed to a basic involvement of MMP in the pathogenesis of rapidly destructive hip OA [3,12,16]. Serum levels of C-terminal cross-linking telopeptide of collagen type I (ICTP) have been shown to reflect degradation of collagen type I in various bone pathologies, including rheumatoid arthritis [10], neuroosteoarthropathy of the foot [18] and aseptic loosening after total hip arthroplasty (THA) [24].…”
Section: Introductionmentioning
confidence: 99%